Bioforce Nanosciences Holdings, Inc. (BFNH)
BFNH is quoted over the counter, not listed on an exchange. Bioforce Nanosciences Holdings, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | BFNH, quoted over the counter |
| SEC CIK | 0001310488 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Laboratory Analytical Instruments |
| Business address | Virginia Beach, VA |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These conditions raise substantial doubt as to the Company's ability to continue as a going concern." | 10-Q 2026-11-09 |
| Cash and burn | $32K cash; operating cash flow -$31K a quarter. | Report 2026-09-30 |
| Shares outstanding | 38,065,914 (2026-11-06); 33,521,755 a year earlier; 29,271,755 three years earlier. | Cover page 2026-11-06 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | MICHAEL GILLESPIE & ASSOCIATES, PLLC, VANCOUVER, Washington, United States | PCAOB Form AP 2026-04-15 |
| Late filings, 12 months | 2 NT notices | NT 10-Q 2026-05-13 |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | Not filed | -$342K | -$95K | $32K | No debt tags | Needs four quarters | 10-Q 2026-11-09 |
| Q2 2026 2026-06-30 | Not filed | $239K | -$27K | $307 | No debt tags | Needs four quarters | 10-Q 2026-08-10 |
| Q1 2026 2026-03-31 | Not filed | -$102K | $7K | $6K | No debt tags | Needs four quarters | 10-Q 2026-05-19 |
| Q4 2025 2025-12-31 | Not filed | -$118K | -$11K | $786 | No debt tags | Needs four quarters | 10-K 2026-04-15 |
| Q3 2025 2025-09-30 | Not filed | -$116K | -$11K | $784 | No debt tags | Needs four quarters | 10-Q 2026-11-09 |
| Q2 2025 2025-06-30 | Not filed | -$123K | -$28K | $905 | No debt tags | Needs four quarters | 10-Q 2026-08-10 |
| Q1 2025 2025-03-31 | Not filed | -$935K | -$15K | $14K | No debt tags | Needs four quarters | 10-Q 2026-05-19 |
| Q4 2024 2024-12-31 | Not filed | -$123K | -$15K | $862 | No debt tags | Needs four quarters | 10-K 2026-04-15 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2008-09-19 |
| Latest annual report | 10-K | 2026-04-15 |
| Latest quarterly / interim | 10-Q | 2026-11-09 |
| Latest current report | 8-K | 2026-10-07 |
| Latest proxy | DEF 14A | 2008-04-14 |
Source: SEC EDGAR submissions feed, 254 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier